MedCity News August 29, 2024
Ron Tilles

This responsibility goes beyond mere box-ticking; it requires a deep, introspective examination of our own biases and blind spots and a genuine commitment to putting the well-being of the communities we serve first.

AI has infiltrated seemingly every facet of business over the last year. The pharmaceutical industry is no different, and this technology’s rapid evolution can change drug development forever. However, the jury is out on whether AI will prove beneficial or detrimental.

On the one hand, the use of AI holds immense potential to revolutionize drug development. It can optimize pricing models, improve access to life-saving treatments, and open up exciting new avenues. The ability to swiftly analyze medical datasets means that researchers can make faster connections...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article